101
|
Conde-Taboada A, Aranegui B, García-Doval I, Dávila-Seijo P, González-Castro U. Empleo de las revisiones sistemáticas en ensayos clínicos y revisiones narrativas en dermatología: ¿se usa la mejor evidencia disponible? ACTAS DERMO-SIFILIOGRAFICAS 2014. [DOI: 10.1016/j.ad.2013.10.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
102
|
Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastián F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina-Gibert M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, García-Doval I. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry. J Eur Acad Dermatol Venereol 2014; 29:156-63. [PMID: 24684267 DOI: 10.1111/jdv.12492] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2013] [Accepted: 03/03/2014] [Indexed: 11/28/2022]
Abstract
BACKGROUND Biobadaderm is the Spanish registry of psoriasis patients receiving systemic treatment in clinical practice. OBJECTIVE To compare the safety of biologics and classic systemic treatment. METHODS Prospective cohort of patients receiving biologics and classic systemic therapies between 2008 and 2013 in 12 hospitals are included. We registered demographic data, diagnoses, comorbidities, treatments and adverse events (AE). We obtained raw relative risks (RR) for specific AE. Multivariate analysis consisted of Cox models adjusting for age, gender, chronic hepatic disease and previous cancer. RESULTS A total of 1030 patients received biologics (2061 AE in 3681 person-years), 926 patients classic systemic drugs (1015 AE in 1517 person-years). Ninety-three per cent of AE in both groups were non-serious, 6% serious and 0.003% fatal. The age- and gender-adjusted hazard ratio of AE was lower in the biologics group [hazard ratio 0.6 (95% CI: 0.5-0.7)].We found no differences in rates of serious and mortal AE. Some system organ class AE rates differed between both groups. As limitations: Prescription bias might affect the incidence of AE in both groups. Association of drug and AE was based on timing: associations might not be causal. CONCLUSION Patients receiving biologics had lower risk of AE. We did not find differences in the risk of serious or fatal AE.
Collapse
|
103
|
Conde-Taboada A, Aranegui B, García-Doval I, Dávila-Seijo P, González-Castro U. The use of systematic reviews in clinical trials and narrative reviews in dermatology: is the best evidence being used? ACTAS DERMO-SIFILIOGRAFICAS 2014; 105:295-9. [PMID: 24661956 DOI: 10.1016/j.adengl.2013.10.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2013] [Accepted: 10/30/2013] [Indexed: 10/25/2022] Open
Abstract
INTRODUCTION AND OBJECTIVES Systematic reviews -the most comprehensive type of literature review-should be taken into account before a clinical trial or a narrative review on a topic is undertaken. The objective of this study was to describe the use of systematic reviews in clinical trials and narrative reviews in dermatology. MATERIAL AND METHODS This was a descriptive cross-sectional study. We selected randomized clinical trials and narrative reviews from the dermatological clinical research journals identified as most important (according to impact factor) and from Actas Dermosifiliográficas, and studied the bibliographies to ascertain whether the authors made reference to existing systematic reviews and Cochrane reviews. RESULTS Of the 72 clinical trials for which a systematic review was available, 24 (33.3%) cited at least 1 review; reference was made to relevant Cochrane reviews in 15.6% of cases and to non-Cochrane reviews in 32%. In the case of the 24 narrative reviews for which a review was available, 10 (41.7%) cited at least 1 review; Cochrane reviews were cited in 20% and non-Cochrane reviews in 35.3%.In the case of Actas Dermosifiliográficas, very few clinical trials were found and the findings for narrative review articles were similar to those observed for the other journals. CONCLUSIONS Systematic reviews are not often taken into account by the authors of clinical trials and narrative reviews and this may lead to redundant studies and publications. Authors appear to use Cochrane reviews even less than non-Cochrane reviews and are therefore ignoring one of the main sources of available evidence.
Collapse
|
104
|
Batalla A, García-Doval I, Peón G, de la Torre C. Estudio de calidad de vida en pacientes con lupus eritematoso cutáneo. ACTAS DERMO-SIFILIOGRAFICAS 2013; 104:800-6. [DOI: 10.1016/j.ad.2013.04.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2012] [Revised: 04/23/2013] [Accepted: 04/27/2013] [Indexed: 11/16/2022] Open
|
105
|
Sánchez-Moya A, García-Doval I, Carretero G, Sánchez-Carazo J, Ferrandiz C, Herrera Ceballos E, Alsina M, Ferrán M, López-Estebaranz JL, Gómez-García F, De la Cueva Dobao P, Carrascosa JM, Vanaclocha F, Belinchón I, Peral F, Dauden E. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry. J Eur Acad Dermatol Venereol 2012; 27:1366-74. [DOI: 10.1111/jdv.12011] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
106
|
Batalla A, García-Doval I. Response to: «Hand Eczema Due to Hygiene and Antisepsis Products: Not Only an Irritative Etiology». ACTAS DERMO-SIFILIOGRAFICAS 2012. [DOI: 10.1016/j.adengl.2012.06.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
107
|
Batalla A, García-Doval I, de la Torre C. Products for Hand Hygiene and Antisepsis: Use by Health Professionals and Relationship With Hand Eczema. ACTAS DERMO-SIFILIOGRAFICAS 2012. [DOI: 10.1016/j.adengl.2012.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
108
|
Batalla A, García-Doval I, Aranegui B, García-Cruz A. Who Funds Research by Spanish Dermatologists? Comparative Analysis of Articles Published in 2008. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/j.adengl.2010.12.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
109
|
Batalla A, Pérez-Pedrosa A, García-Doval I, González-Barcala F, Rosón E, De la Torre C. Pioderma gangrenoso con afectación pulmonar: caso clínico y revisión de la literatura. ACTAS DERMO-SIFILIOGRAFICAS 2011; 102:373-7. [DOI: 10.1016/j.ad.2010.12.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2010] [Revised: 11/03/2010] [Accepted: 12/08/2010] [Indexed: 11/25/2022] Open
|
110
|
Batalla A, García-Doval I, Aranegui B, García-Cruz A. [Who funds research by Spanish dermatologists? Comparative analysis of articles published in 2008]. ACTAS DERMO-SIFILIOGRAFICAS 2011; 102:517-26. [PMID: 21444060 DOI: 10.1016/j.ad.2010.12.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2010] [Revised: 11/12/2010] [Accepted: 12/06/2010] [Indexed: 10/17/2022] Open
Abstract
BACKGROUND References have been made in the literature to the funding of clinical trials by the pharmaceutical industry. Other types of funding, however, have been less well studied. OBJECTIVE To describe the sources of funding for research by Spanish dermatology departments published in 2008. MATERIAL AND METHODS A bibliometric study was performed of the research articles published by Spanish, French, and British dermatology departments and by Spanish rheumatology departments in 2008 according to MEDLINE records. RESULTS Articles published by Spanish dermatology departments received funding in 36.4% of cases. This percentage is lower than that found for the other groups studied and remained low for all different types of funding. Statistically significant relationships were found between a higher percentage of funding and a higher level of evidence, as well as between a higher level of funding by the pharmaceutical industry and the publication of research into quality of life and pharmacological treatment. Inadequate declaration of funding was observed in 57.1% of articles from Spanish dermatology departments and the role of the sponsor was not declared in any article. Similar findings were obtained for the other groups studied. CONCLUSIONS The proportion of research articles published by Spanish dermatology departments that receive external funding is low, and this is associated with a lower level of scientific evidence. In order to obtain more external funding, we must improve our competitiveness.
Collapse
|
111
|
Posada C, García-Cruz A, García-Doval I, Millán BS, Teijeira S. Chloroquine-induced myopathy. Lupus 2011; 20:773-4. [DOI: 10.1177/0961203310385553] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
112
|
Cabanillas M, García-Doval I, Monteagudo B, Suárez-Amor O, Allegue F, Pérez-Pérez L, Ginarte M, Labandeira J, Zulaica A. Reproducibility of the Diagnosis of Onychomycosis by Dermatologists in a Clinical Setting. ACTAS DERMO-SIFILIOGRAFICAS 2011. [DOI: 10.1016/s1578-2190(11)70825-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
113
|
Rivera R, García-Doval I, Carretero G, Daudén E, Sánchez-Carazo J, Ferrándiz C, Herrera E, Alsina M, Ferrán M, López-Estebaranz J, Gómez F, Herranz J, Carrascosa J, Vanaclocha F. BIOBADADERM, the Spanish Registry of Adverse Events Associated With Biologic Drugs in Dermatology: First Report. ACTAS DERMO-SIFILIOGRAFICAS 2011. [DOI: 10.1016/s1578-2190(11)70770-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
114
|
García-Doval I. Citas inadecuadas en «La leucoplasia oral: Definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica» referentes al fraude Sudbo. ACTAS DERMO-SIFILIOGRAFICAS 2010. [DOI: 10.1016/j.ad.2009.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
115
|
García-Doval I. [Inappropriate references in "Oral leukoplakia: Clinical, histopathologic, and molecular features and therapeutic approach" to the Sudbo fraud]. ACTAS DERMO-SIFILIOGRAFICAS 2010; 101:284; author reply 284. [PMID: 20398614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023] Open
|
116
|
González-Sixto B, García-Doval I, Oliveira R, Posada C, García-Cruz M, Cruces M. Aspectos prácticos de la quinacrina como tratamiento del lupus eritematoso cutáneo: serie de casos. ACTAS DERMO-SIFILIOGRAFICAS 2010. [DOI: 10.1016/j.ad.2009.07.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
117
|
González-Sixto B, García-Doval I, Oliveira R, Posada C, García-Cruz MA, Cruces M. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series]. ACTAS DERMO-SIFILIOGRAFICAS 2010; 101:54-58. [PMID: 20109393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
Hydroxychloroquine and chloroquine are antimalarials used as first-line treatment of cutaneous lupus. Quinacrine is not often employed by Spanish physicians due to a lack of information about its use and the fact that it is not marketed in Spain. It is effective in monotherapy or in combination therapy with other antimalarials. One of the advantages of quinacrine over chloroquine and hydroxychloroquine is that it does not appear to cause retinal toxicity. Quinacrine is used as second-line therapy in patients with pre-existing eye problems that contraindicate treatment with chloroquine or hydroxychloroquine (after evaluation of which drug has the better risk-benefit relationship), and in combination therapy with other antimalarials inpatients with resistance or only a partial response to chloroquine or hydroxychloroquine. We report 8 cases of patients with cutaneous lupus who received treatment with quinacrine in monotherapy or in combination with others antimalarials. Lesions resolved in 5 patients and improved in 3. Therapy had to be withdrawn in 1 patient due to an exacerbation of his psoriasis.
Collapse
|
118
|
González-Sixto B, García-Doval I, Oliveira R, Posada C, García-Cruz M, Cruces M. Quinacrine in the Treatment of Cutaneous Lupus Erythematosus: Practical Aspects and a Case Series. ACTAS DERMO-SIFILIOGRAFICAS 2010. [DOI: 10.1016/s1578-2190(10)70580-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
119
|
García-Doval I. Geoffrey Rose and How to Foster Clinical Research in Spanish Dermatology. ACTAS DERMO-SIFILIOGRAFICAS 2010; 101:470-2. [DOI: 10.1016/s1578-2190(10)70831-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
120
|
Posada C, García-Doval I, de la Torre C, Cruces MJ. [Value of palmar and plantar biopsies of hyperkeratotic and vesicular pustular lesions: a cross-sectional study]. ACTAS DERMO-SIFILIOGRAFICAS 2010; 101:103-105. [PMID: 20109407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
|
121
|
Posada C, García-Doval I, de la Torre C, Cruces M. Utilidad de las biopsias palmoplantares en lesiones hiperqueratósicas y vesiculopustulosas. Estudio transversal. ACTAS DERMO-SIFILIOGRAFICAS 2010. [DOI: 10.1016/j.ad.2009.07.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
122
|
Posada C, García-Doval I, de la Torre C, Cruces M. Value of Palmar and Plantar Biopsies of Hyperkeratotic and Vesicular Pustular Lesions: A Cross-sectional Study. ACTAS DERMO-SIFILIOGRAFICAS 2010. [DOI: 10.1016/s1578-2190(10)70594-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
123
|
Aranegui B, García-Doval I, García-Cruz A. Clinical Research Publication by Spanish Dermatologists Over Time and in Comparison With Other Research Groups in 2008. ACTAS DERMO-SIFILIOGRAFICAS 2010; 101:534-41. [DOI: 10.1016/s1578-2190(10)70838-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
124
|
García-Doval I, Naldi L. [Introduction to clinical research in dermatology: the link between clinical practice and research]. ACTAS DERMO-SIFILIOGRAFICAS 2009; 100:749-755. [PMID: 19889295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
Clinical research involves studying patients with a view to improving their care. It enhances the health system, benefits both patients and physicians, and represents the "natural" form of investigation for physicians. It can be conducted at both large and small sites. On initiating a line of research, a specific question should be formulated in terms of PICO (patient, intervention, comparison, and outcome). Each of these components should be precisely defined.The question will subsequently be assessed using the FINER mnemonic (that is, whether it is feasible, interesting, novel, ethical, and relevant). If shortcomings are detected, the research question can be refined or rejected directly. When we have an appropriate question,the next step will be to write our protocol with the assistance of someone trained in clinical research methodology.
Collapse
|
125
|
García-Doval I, Naldi L. Introducción a la investigación clínica en Dermatología. Un nexo entre clínica e investigación. ACTAS DERMO-SIFILIOGRAFICAS 2009. [DOI: 10.1016/s0001-7310(09)72547-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|